Global Celecoxib Market Size to Surpass US$ 2062.6 Million By 2027-Says QYResearch Report

QY Research has made a brilliant attempt to elaborately and meticulously analyze the global Celecoxib market in its latest report. All of the market forecasts presented in the report are authentic and reliable.

Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects. The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs. Data show that more than 400 million people worldwide are currently affected by joint diseases. The prevalence of osteoarthritis is 17 percent among people aged 40, 62 percent among people over 60 and 80 percent among people over 75. The number of patients with arthritis in mainland China is more than 10% of the total population, well over 100 million, and the incidence of arthritis increases with age, and the number of patients is still increasing. At present, the burden of chronic diseases will increase by 40% due to the aging of the population. As the population ages, anti-inflammatory and anti-rheumatic drugs will enter a phase of rapid growth. Globally, whether prescription drugs or non-prescription drugs, Xibu is widely used in clinical practice. At present, the best seller in the international market is Celixib. Celixib market will continue to grow steadily in the next few years. At present, the global Celecoxib market is basically occupied by Pfizer, which has formed an oligopoly. It accounted for 63.39% of the global market in 2019. As of 2019, China relies entirely on Pfizer for celecoxib imports. Since 2020, some domestic drug companies have been gradually approved by FDA and CFDA. The introduction of celecoxib generic drugs by local companies will break the monopoly of import. Market Analysis and Insights: Global Celecoxib Market The global Celecoxib market size is projected to reach US$ 2062.6 million by 2027, from US$ 1175.4 million in 2020, at a CAGR of 8.4% during 2021-2027.

Request Sample Report and Full Report TOC: 

https://www.qyresearch.com/sample-form/form/3271483/global-celecoxib-market

The Essential Content Covered in the Global Celecoxib Market Report :

* Top Key Company Profiles.
* Main Business and Rival Information
* SWOT Analysis and PESTEL Analysis
* Production, Sales, Revenue, Price and Gross Margin
* Market Share and Size

Top Players of Celecoxib Market are Studied: Pfizer Inc, Teva, Mylan, Apotex, Lupin, Hengrui Medicine

The report provides a 6-year forecast (2021-2027) assessed based on how the Celecoxib market is predicted to grow in major regions like USA, Europe, Japan, China, India, Southeast Asia, South America, South Africa, Others.

Segmentation by Type:  50mg, 100mg, 200mg, 400mg

Segmentation by Application:  Rheumatoid arthritis, osteoarthritis, Acute pain, Musculoskeletal pain, Other diseases

Get Full Customize report or for any Special Discount visit@  
https://www.qyresearch.com/customize-request/form/3271483/global-celecoxib-market
Reasons to Buy this Report:

Industry Size & Forecast: Estimations on the global Celecoxib industry size on the basis of value and volume are provided in this part of the report
Study on Key Industry Trends: This section offers deep insights into the prevailing and upcoming Celecoxib trends
Segmental Analysis: Here, the report has examined the high-growth segments including product type, application, and end-users, taking into account their CAGR, share, and size
Future Prospects: Current Celecoxib developments and future opportunities estimated to emerge in the Celecoxib industry are looked into in this portion of the study
Geography-wise Analysis: The authors of the report have studied the regions having growth potential to help companies plan their future investments
Study on Competitive Landscape: The industry experts have offered thorough information about the strategic tactics adopted by the industry participants to consolidate their position. This assessment will help the players to strategize their activities in future.
TOC

1 Celecoxib Market Overview
1.1 Celecoxib Product Overview
1.2 Celecoxib Market Segment by Type
1.2.1 50mg
1.2.2 100mg
1.2.3 200mg
1.2.4 400mg
1.3 Global Celecoxib Market Size by Type
1.3.1 Global Celecoxib Market Size Overview by Type (2016-2027)
1.3.2 Global Celecoxib Historic Market Size Review by Type (2016-2021)

1.3.2.1 Global Celecoxib Sales Breakdown in Volume by Type (2016-2021)

1.3.2.2 Global Celecoxib Sales Breakdown in Value by Type (2016-2021)

1.3.2.3 Global Celecoxib Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Celecoxib Forecasted Market Size by Type (2022-2027)

1.3.3.1 Global Celecoxib Sales Breakdown in Volume by Type (2022-2027)

1.3.3.2 Global Celecoxib Sales Breakdown in Value by Type (2022-2027)

1.3.3.3 Global Celecoxib Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Celecoxib Sales Breakdown by Type (2016-2021)
1.4.2 Europe Celecoxib Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Celecoxib Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Celecoxib Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Celecoxib Sales Breakdown by Type (2016-2021) 2 Global Celecoxib Market Competition by Company
2.1 Global Top Players by Celecoxib Sales (2016-2021)
2.2 Global Top Players by Celecoxib Revenue (2016-2021)
2.3 Global Top Players Celecoxib Price (2016-2021)
2.4 Global Top Manufacturers Celecoxib Manufacturing Base Distribution, Sales Area, Product Type
2.5 Celecoxib Market Competitive Situation and Trends
2.5.1 Celecoxib Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Celecoxib Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Celecoxib as of 2020)
2.7 Date of Key Manufacturers Enter into Celecoxib Market
2.8 Key Manufacturers Celecoxib Product Offered
2.9 Mergers & Acquisitions, Expansion 3 Celecoxib Status and Outlook by Region
3.1 Global Celecoxib Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Celecoxib Historic Market Size by Region
3.2.1 Global Celecoxib Sales in Volume by Region (2016-2021)
3.2.2 Global Celecoxib Sales in Value by Region (2016-2021)
3.2.3 Global Celecoxib Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Celecoxib Forecasted Market Size by Region
3.3.1 Global Celecoxib Sales in Volume by Region (2022-2027)
3.3.2 Global Celecoxib Sales in Value by Region (2022-2027)
3.3.3 Global Celecoxib Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Celecoxib by Application
4.1 Celecoxib Market Segment by Application
4.1.1 Rheumatoid arthritis
4.1.2 osteoarthritis
4.1.3 Acute pain
4.1.4 Musculoskeletal pain
4.1.5 Other diseases
4.2 Global Celecoxib Market Size by Application
4.2.1 Global Celecoxib Market Size Overview by Application (2016-2027)
4.2.2 Global Celecoxib Historic Market Size Review by Application (2016-2021)

4.2.2.1 Global Celecoxib Sales Breakdown in Volume, by Application (2016-2021)

4.2.2.2 Global Celecoxib Sales Breakdown in Value, by Application (2016-2021)

4.2.2.3 Global Celecoxib Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Celecoxib Forecasted Market Size by Application (2022-2027)

4.2.3.1 Global Celecoxib Sales Breakdown in Volume, by Application (2022-2027)

4.2.3.2 Global Celecoxib Sales Breakdown in Value, by Application (2022-2027)

4.2.3.3 Global Celecoxib Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Celecoxib Sales Breakdown by Application (2016-2021)
4.3.2 Europe Celecoxib Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Celecoxib Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Celecoxib Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Celecoxib Sales Breakdown by Application (2016-2021) 5 North America Celecoxib by Country
5.1 North America Celecoxib Historic Market Size by Country
5.1.1 North America Celecoxib Sales in Volume by Country (2016-2021)
5.1.2 North America Celecoxib Sales in Value by Country (2016-2021)
5.2 North America Celecoxib Forecasted Market Size by Country
5.2.1 North America Celecoxib Sales in Volume by Country (2022-2027)
5.2.2 North America Celecoxib Sales in Value by Country (2022-2027) 6 Europe Celecoxib by Country
6.1 Europe Celecoxib Historic Market Size by Country
6.1.1 Europe Celecoxib Sales in Volume by Country (2016-2021)
6.1.2 Europe Celecoxib Sales in Value by Country (2016-2021)
6.2 Europe Celecoxib Forecasted Market Size by Country
6.2.1 Europe Celecoxib Sales in Volume by Country (2022-2027)
6.2.2 Europe Celecoxib Sales in Value by Country (2022-2027) 7 Asia-Pacific Celecoxib by Region
7.1 Asia-Pacific Celecoxib Historic Market Size by Region
7.1.1 Asia-Pacific Celecoxib Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Celecoxib Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Celecoxib Forecasted Market Size by Region
7.2.1 Asia-Pacific Celecoxib Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Celecoxib Sales in Value by Region (2022-2027) 8 Latin America Celecoxib by Country
8.1 Latin America Celecoxib Historic Market Size by Country
8.1.1 Latin America Celecoxib Sales in Volume by Country (2016-2021)
8.1.2 Latin America Celecoxib Sales in Value by Country (2016-2021)
8.2 Latin America Celecoxib Forecasted Market Size by Country
8.2.1 Latin America Celecoxib Sales in Volume by Country (2022-2027)
8.2.2 Latin America Celecoxib Sales in Value by Country (2022-2027) 9 Middle East and Africa Celecoxib by Country
9.1 Middle East and Africa Celecoxib Historic Market Size by Country
9.1.1 Middle East and Africa Celecoxib Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Celecoxib Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Celecoxib Forecasted Market Size by Country
9.2.1 Middle East and Africa Celecoxib Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Celecoxib Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Celecoxib Business
10.1 Pfizer Inc
10.1.1 Pfizer Inc Corporation Information
10.1.2 Pfizer Inc Introduction and Business Overview
10.1.3 Pfizer Inc Celecoxib Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Pfizer Inc Celecoxib Products Offered
10.1.5 Pfizer Inc Recent Development
10.2 Teva
10.2.1 Teva Corporation Information
10.2.2 Teva Introduction and Business Overview
10.2.3 Teva Celecoxib Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Teva Celecoxib Products Offered
10.2.5 Teva Recent Development
10.3 Mylan
10.3.1 Mylan Corporation Information
10.3.2 Mylan Introduction and Business Overview
10.3.3 Mylan Celecoxib Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Mylan Celecoxib Products Offered
10.3.5 Mylan Recent Development
10.4 Apotex
10.4.1 Apotex Corporation Information
10.4.2 Apotex Introduction and Business Overview
10.4.3 Apotex Celecoxib Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Apotex Celecoxib Products Offered
10.4.5 Apotex Recent Development
10.5 Lupin
10.5.1 Lupin Corporation Information
10.5.2 Lupin Introduction and Business Overview
10.5.3 Lupin Celecoxib Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Lupin Celecoxib Products Offered
10.5.5 Lupin Recent Development
10.6 Hengrui Medicine
10.6.1 Hengrui Medicine Corporation Information
10.6.2 Hengrui Medicine Introduction and Business Overview
10.6.3 Hengrui Medicine Celecoxib Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Hengrui Medicine Celecoxib Products Offered
10.6.5 Hengrui Medicine Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Celecoxib Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Celecoxib Industrial Chain Analysis
11.4 Celecoxib Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Celecoxib Distributors
12.3 Celecoxib Downstream Customers 13 Research Findings and Conclusion 14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

 
 

Contact US:
QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA - 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com

About Us

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry. 

This release was published on openPR.